Mansell Holly, Zaslawski Zina, Mbabaali Sophia, King Patricia M, Kelly Lauren E, Lougheed Taylor, Anderson Jennifer, Huntsman Richard J, Alcorn Jane
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada.
Paediatr Child Health. 2023 May 4;28(2):102-106. doi: 10.1093/pch/pxac099. eCollection 2023 May.
Implementing medical cannabis (MC) into a child's daily routine can be challenging and there is a lack of guidance for its therapeutic use in schools in Canada. Our objective was to learn about the experiences of caregivers of school-aged children who require MC.
Qualitative description was used and caregivers were interviewed about MC in schools and in general. The transcripts were entered into Dedoose software for qualitative analysis and content analysis was performed. Sentences and statements were ascribed line by line into meaning units and labelled with codes, and organized according to categories and subcategories.
Twelve caregivers of school-aged children who take MC participated. The most common reasons for treatment were drug-resistant epilepsy (DRE), autism, or other developmental disorders. Approximately half of the participants' children (n = 6) took MC during the school day and most (5/6) perceived their experiences to be positive or neutral but reported a lack of knowledge about MC. While data saturation was not reached regarding MC in schools, rich dialogues were garnered about MC in general and three categories were identified: challenges (subcategories stigma, finding an authorizer, cost, dosing, and supply); parents as advocates (subcategories required knowledge, attitudes, skills, and sources of information); and caregiver relief for positive outcomes.
Caregivers demonstrate remarkable tenacity despite the many challenges associated with MC use. Education and practice change are needed to ensure that children using MC can benefit from or continue to experience its positive outcomes within the school environment and beyond.
将医用大麻纳入儿童日常生活具有挑战性,且加拿大学校在其治疗用途方面缺乏指导。我们的目的是了解需要使用医用大麻的学龄儿童照料者的经历。
采用定性描述法,就学校及总体情况对照料者进行了访谈。访谈记录录入Dedoose软件进行定性分析,并开展了内容分析。逐句逐段将语句归纳为意义单元,进行编码,并按照类别和子类别进行整理。
12名使用医用大麻的学龄儿童照料者参与了研究。最常见的治疗原因是耐药性癫痫、自闭症或其他发育障碍。约半数参与者的孩子(n = 6)在上学期间使用医用大麻,大多数(5/6)认为他们的经历是积极的或中性的,但表示对医用大麻缺乏了解。虽然在学校使用医用大麻方面未达到数据饱和,但就医用大麻总体情况收集到了丰富的对话内容,并确定了三个类别:挑战(子类别包括污名化、寻找授权者、成本、剂量和供应);家长作为倡导者(子类别包括所需知识、态度、技能和信息来源);以及照料者因积极结果而感到宽慰。
尽管使用医用大麻存在诸多挑战,但照料者表现出了非凡的韧性。需要开展教育并改变做法,以确保使用医用大麻的儿童能够在学校环境及其他环境中受益于或继续体验其积极效果。